This compound is a pharmaceutical intermediate with a thiazole core and a nitrile-substituted phenol group. Its structure features aromatic rings, an ester functional group, and moderate polarity, indicating potential utility in organic synthesis and drug development.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 161798-02-3
Ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
pharmaceutical intermediate
Cis-Octahydro-1H-isoindole hydrochloride
Pharmaceutical intermediate for drug synthesis
Alogliptin Impurity 07
Pharmaceutical impurity reference standard
3-QUINUCLIDINOL
precursor in pharmaceutical synthesis
5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester
Pharmaceutical intermediate
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
Pharmaceutical intermediate for thiazole derivatives
Febuxostat
active pharmaceutical ingredient
ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
WTMZFYPEMMFHPR-UHFFFAOYSA-N
CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)O)C#N)C